Loading
Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹2,128Admitted-Finance | ₹2,128 | L1 | Admitted-Finance |
| 2 | L2₹2,157.12+₹29.12 (1.37%)Admitted-Finance | ₹2,157.12+₹29.12 (1.37%) | L2 | Admitted-Finance |
| 3 | L3₹2,182.88+₹54.88 (2.58%)Admitted-Finance CIPLA HOUSE PENINSULA BUSINESS PARK GANPATRAO KADAM MARG LOWER PAREL MUMBAI MAHARASHTRA 400013 | MUMBAI | MAHARASHTRA | 400013 | ₹2,182.88+₹54.88 (2.58%) | L3 | Admitted-Finance |
| Sl No | Description | Qty | Unit | JUBILANT GENERICS LIMITED L1 | Mylan Laboratories Limited L2 | Cipla Ltd L3 |
|---|---|---|---|---|---|---|
| 1.00 | Inj. Remdesivir 100mg | 2,00,000 | vial | - | - | - |
Tender Value
₹50 Cr
EMD Value
₹5 L
Closing Date
21 Sept 2020, 3:00 pmClosed
MD, RMSCL
Conferance Hall, RMSCL, Swasthyabhawan, Tilak Marg, Jaipur
Drug and medicine
2020_RMSCL_198666_1
F.02 302 RMSCL PROC DRUG NIB-25 20201665 08 09 20
Open Tender
Supply of Materials/Hiring of Goods
Item Wise
60 days
all ddw mcdw and head quarter rajasthan
Manufacturing Licence, PP, MSC, NCC, GMP/WHO-GMP, Turn Over, Bid Security, RISL Fees, Bid Forms Fees And All Annexure, Etc
4 documents required · 4 mandatory
₹2,000
MD, RMSCL
₹5 L
Yes
24 Sept 2020
9 Sept 2020
21 Sept 2020
9 Sept 2020
21 Sept 2020
9 Sept 2020
Inj. Remdesivir 100mg
Mylan Laboratories Limited
Cipla Ltd
stage.html
html • 0.03 MB
tech_bid_open.pdf
tech_eval.pdf
fin_bid_open.pdf
boq_comp_chart.xlsx
xlsx
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Tendernotice_1.pdf
PDF • 0.07 MB
Tender25.pdf
Tender Documents • 2.17 MB
BOQ_353434.xls
BOQ • 0.27 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .